Align Technology (ALGN) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Align Technology

NasdaqGS•Healthcare•Medical Instruments & Supplies

$149.71-0.74(<0.01%)After hours

Market Cap

$10.76B

P/E

26.0x

P/S

2.6x

P/B

2.5x

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

How this company scores

GoodMetricSide Score: 62/100

Strongest: Cash & Earnings Quality (21/25); weakest: Growth (13/25).

Profitability13/25

Growth13/25

Balance Sheet & Red Flags15/25

Cash & Earnings Quality21/25

Strengths

Interest easily coveredCash-backed earningsConsistent free cash flowConsistent growth

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 26.0x5y range 24.2x – 83.3x

Currently below its 20-quarter median.

P/S · 2.6x5y range 2.3x – 14.1x

Currently below its 20-quarter median.

P/B · 2.5x5y range 2.3x – 15.1x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

Some Concerns

Margin Pressure

Watch

Operating margins declined 12.9% — watch for continued compression, which may signal competitive or cost pressure.

Price & Volume

Market Cap $10.76B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $4.14B
Q. Revenue: $1.06B
TTM EBITDA: $801.98M
TTM Op. Income: $547.59M
Q. Op. Income: $154.01M
TTM Net Income: $413.58M
Q. Net Income: $108.29M
EPS: $1.51
Shares Out.: $71.50M

$4.14B in TTM revenue grew 4.4% YoY, reaching $1.06B last quarter. TTM EBITDA of $801.98M and TTM operating income of $547.59M show growth is flowing through to the bottom line. TTM net income of $413.58M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 4 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 71.7%
EBITDA Margin: 18.4%
Op. Margin: 14.6%
Net Margin: 10.3%

Op. margin of 14.6% is down 1.5% YoY — costs are rising relative to revenue. Net margin at 10.3% and gross margin of 71.7% show how much of each revenue dollar survives to profit. Over the past year, operating margin is down 9% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 26.0x
P/S Ratio: 2.6x
P/B Ratio: 2.5x

At 26.0x P/E, the stock trades within typical market levels. P/S of 2.6x and P/B of 2.5x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is down 17% — an improving trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $6.42B
Cash: $1.10B
Long-Term Debt: N/A
Book Value: $4.23B
D/E Ratio: N/A
Debt/EBITDA: 0.0

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $192.76M
TTM Free Cash Flow: $633.57M
FCF Margin: 15.3%
FCF / Net Income: 1.5

TTM FCF of $633.57M on $192.76M in operating cash flow. The FCF / Net Income ratio of 1.5x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has risen for 2 consecutive quarters — an improving trend.